📣 VC round data is live. Check it out!

Morgan Stanley Emerg Mkts Valuation Multiples

Discover revenue and EBITDA valuation multiples for Morgan Stanley Emerg Mkts and similar public comparables like Xlife Sciences, DAOL Investment, Triple Point Venture VCT, GalaxyEdge Acquisition and more.

Morgan Stanley Emerg Mkts Overview

About Morgan Stanley Emerg Mkts

Morgan Stanley Emerg Mkts Debt Fd Inc is a diversified, closed-end management investment company. The Fund's primary investment objective is to produce high current income and as a secondary objective to seek capital appreciation, through investments mainly in debt securities of government and government-related issuers located in emerging countries, of entities organized to restructure the outstanding debt of such issuers and debt securities of corporate issuers in or organized under the laws of emerging countries.


Founded

1993

HQ

United States

Employees

N/A

Sectors

Financials (FY)

Revenue: $22M
Net Income: $21M

EV

$148M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Morgan Stanley Emerg Mkts Financials

Morgan Stanley Emerg Mkts reported last fiscal year revenue of $22M.

In the same fiscal year, Morgan Stanley Emerg Mkts generated $21M in net income.


Morgan Stanley Emerg Mkts P&L

In the most recent fiscal year, Morgan Stanley Emerg Mkts reported revenue of $22M and net income of $21M.

Morgan Stanley Emerg Mkts is profitable as of last fiscal year, with net margin of 97%.

See analyst estimates for Morgan Stanley Emerg Mkts
Last FY202320242025202620272028
Revenue$22M$18M$17M$22M
Net Profit$21M$17M$16M$21M
Net Margin97%97%97%97%

Financial data powered by Morningstar, Inc.

Morgan Stanley Emerg Mkts Stock Performance

Morgan Stanley Emerg Mkts has current market cap of $148M, and enterprise value of $148M.


Morgan Stanley Emerg Mkts' stock price is $7.31.

Morgan Stanley Emerg Mkts has an EPS (earnings per share) of $1.04.

See more trading valuation data for Morgan Stanley Emerg Mkts
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$148M$148M1.1%$1.04

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Morgan Stanley Emerg Mkts Valuation Multiples

Morgan Stanley Emerg Mkts trades at 6.8x EV/Revenue multiple.

See NTM and 2027E valuation multiples for Morgan Stanley Emerg Mkts

Morgan Stanley Emerg Mkts Financial Valuation Multiples

As of May 21, 2026, Morgan Stanley Emerg Mkts has market cap of $148M and EV of $148M.

Morgan Stanley Emerg Mkts has a P/E ratio of 7.0x.

Last FY202320242025202620272028
EV/Revenue6.8x8.4x8.8x6.8x
P/E7.0x8.7x9.0x7.0x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Morgan Stanley Emerg Mkts Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Morgan Stanley Emerg Mkts Margins & Growth Rates

In the most recent fiscal year, Morgan Stanley Emerg Mkts reported net margin of 97%.

See estimated margins and future growth rates for Morgan Stanley Emerg Mkts

Morgan Stanley Emerg Mkts Margins

Last FY20242025202720282029
Net Margin97%97%97%

Morgan Stanley Emerg Mkts Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth(4%)29%
Net Profit Growth(4%)29%

Data powered by FactSet, Inc. and Morningstar, Inc.

Morgan Stanley Emerg Mkts Operational KPIs

Access forward-looking KPIs for Morgan Stanley Emerg Mkts
Last FY202320242025202620272028
G&A Expenses to Revenue3%3%3%3%
Opex to Revenue3%3%3%3%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Morgan Stanley Emerg Mkts Competitors

Morgan Stanley Emerg Mkts competitors include Xlife Sciences, DAOL Investment, Triple Point Venture VCT, GalaxyEdge Acquisition, Kinea Oportunidades Real Estate FII, Spectral Capital, Arbona, Creal, Rbr Log FII and Binhai Investment Co.

Most Morgan Stanley Emerg Mkts public comparables operate across PE & VC.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Xlife Sciences641.5x(57.9x)
DAOL Investment0.7x
Triple Point Venture VCT76.2x
GalaxyEdge Acquisition(3471.3x)
Kinea Oportunidades Real Estate FII4.1x
Spectral Capital
Arbona0.9x5.7x
Creal0.2x0.2x4.2x

This data is available for Pro users. Sign up to see all Morgan Stanley Emerg Mkts competitors and their valuation data.

Start Free Trial

Morgan Stanley Emerg Mkts Investment Activity

Morgan Stanley Emerg Mkts has invested in 1 company to date.

Latest investment by Morgan Stanley Emerg Mkts was on May 18th 2026. Morgan Stanley Emerg Mkts invested in Commure in their $70M Undisclosed stage round (EV/Revenue multiple of ).

See VC round multiples

Latest Investments by Morgan Stanley Emerg Mkts

Commure
Description
Commure is a San Francisco-headquartered healthcare technology company that delivers an interconnected platform for hospital and health system operations. Its suite of applications includes ambient AI-assisted clinical documentation, revenue cycle automation, staff safety monitoring, and care coordination tools. The platform integrates seamlessly with electronic health record systems through partnerships like the MEDITECH Alliance and enables enterprise-wide AI deployments such as ambient scribing and clinician workflow automation. Commure supports provider networks by offering licensing, implementation services, and content integration to streamline clinical and administrative workflows across large-scale organizations.
HQ CountryUnited States
HQ City
San Francisco, CA
Deal Date18 May 2026
RoundUndisclosed stage
Raised$70M
InvestorsGeneral Catalyst; Kirkland & Ellis; Morgan Stanley Emerg Mkts; Jim Goetz
Valuation$7B
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Morgan Stanley Emerg Mkts investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Morgan Stanley Emerg Mkts

When was Morgan Stanley Emerg Mkts founded?Morgan Stanley Emerg Mkts was founded in 1993.
Where is Morgan Stanley Emerg Mkts headquartered?Morgan Stanley Emerg Mkts is headquartered in United States.
Is Morgan Stanley Emerg Mkts publicly listed?Yes, Morgan Stanley Emerg Mkts is a public company listed on NYSE.
What is the stock symbol of Morgan Stanley Emerg Mkts?Morgan Stanley Emerg Mkts trades under MSD ticker.
Who are competitors of Morgan Stanley Emerg Mkts?Morgan Stanley Emerg Mkts main competitors include Xlife Sciences, DAOL Investment, Triple Point Venture VCT, GalaxyEdge Acquisition, Kinea Oportunidades Real Estate FII, Spectral Capital, Arbona, Creal, Rbr Log FII, Binhai Investment Co.
What is the current market cap of Morgan Stanley Emerg Mkts?Morgan Stanley Emerg Mkts' current market cap is $148M.
What is the current revenue of Morgan Stanley Emerg Mkts?Morgan Stanley Emerg Mkts' last fiscal year revenue is $22M.
What is the current EV/Revenue multiple of Morgan Stanley Emerg Mkts?Current revenue multiple of Morgan Stanley Emerg Mkts is 6.8x.
Is Morgan Stanley Emerg Mkts profitable?No, Morgan Stanley Emerg Mkts is not profitable.
How many companies Morgan Stanley Emerg Mkts has acquired to date?Morgan Stanley Emerg Mkts hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Morgan Stanley Emerg Mkts has invested to date?As of May 2026, Morgan Stanley Emerg Mkts has invested in 1 company.
What was the last Morgan Stanley Emerg Mkts investment?On 18th May 2026 Morgan Stanley Emerg Mkts invested in Commure, participating in a $70M Undisclosed stage round at $7B valuation, alongside General Catalyst, Kirkland & Ellis, and Jim Goetz.
In what companies Morgan Stanley Emerg Mkts invested in?Morgan Stanley Emerg Mkts invested in Commure.

See public comps similar to Morgan Stanley Emerg Mkts

Lists including Morgan Stanley Emerg Mkts

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial